Phathom Pharmaceuticals, Inc. (PHAT)
15.02
-0.58
(-3.75%)
USD |
NASDAQ |
Jan 09, 16:00
15.02
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals EPS Diluted (Quarterly): -0.4084 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Immuneering Corp. | -0.3772 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.97M |
| Revenue (Quarterly) | 49.50M |
| Total Expenses (Quarterly) | 79.48M |
| Enterprise Value | 1.619B |
| Gross Profit Margin (Quarterly) | 87.50% |
| Profit Margin (Quarterly) | -60.55% |
| Earnings Yield | -25.39% |
| Normalized Earnings Yield | -25.39 |